This Is MS Multiple Sclerosis Knowledge & Support Community

Welcome to This is MS, the leading forum for Multiple Sclerosis research and support. Join our friendly community of patients, caregivers, and researchers celebrating over 20 years of delivering hope through knowledge.
https://www.thisisms.com/forum/

Evobrutinib, promising BTK inhibitor

https://www.thisisms.com/forum/viewtopic.php?t=32334

Page 1 of 1

Evobrutinib, promising BTK inhibitor

Posted: Tue Feb 14, 2023 12:43 am
by DIM
https://www.merckgroup.com/en/news/evob ... -2022.html

Re: Evobrutinib, promising BTK inhibitor

Posted: Mon Dec 02, 2024 2:49 pm
by DIM
Results from the EVOLUTION clinical trials showed evobrutinib did not meet its primary endpoint of annualized relapse rate for up to 156 weeks compared to oral teriflunomide in both studies:

https://www.emdgroup.com/en/news/evobru ... redirect=1
All times are UTC-08:00
Page 1 of 1

Powered by phpBB® Forum Software © phpBB Limited